Margo Holland has been named vice president of Global Quality at Worldwide Clinical Trials. In her new role, Ms. Holland will be responsible for the implementation of a risk-based clinical quality management system to ensure compliance with international regulations for a full range of services associated with the conduct of clinical trials, including clinical and medical monitoring, project management, data management, pharmacovigilance, depot services, and biostatistics.
 
“We’re delighted to welcome Margo to the Worldwide team. She is an outstanding Quality Assurance (QA) leader who has the right mix of skills, passion and leadership expertise to ensure that our work is held to the absolute highest quality standards,” said Peter Benton, president and chief operating officer at Worldwide. “Quality is the backbone of our company and is what our customers expect and demand. From her time as a bedside critical care nurse and lead CRA, to leadership roles in clinical operations and QA, along with her auditing and compliance activities – Margo’s rich and diverse experience is exactly what we need.”
 
Ms. Holland has held a variety of leadership roles within CROs and pharmaceutical companies. Previously she served as the Quality Assurance head of Good Clinical Practices (GCP), Good Pharmacoepidemiology Practices (GPP) and, most recently, head of Good Laboratory Practices (GLP) for Vertex Pharmaceuticals Inc., where she was a key to the strategy development and deployment of the company’s GxP Quality Management System.